Cargando…
SARS-CoV-2 Delta and delta derivatives impact on neutralization of Covishield recipient sera
Autores principales: | Sahay, Rima R., Patil, Deepak Y., Sapkal, Gajanan N., Deshpande, Gururaj R., Shete, Anita M., Nyayanit, Dimpal A., Kumar, Sanjay, Yadav, Pragya D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The British Infection Association. Published by Elsevier Ltd.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8857767/ https://www.ncbi.nlm.nih.gov/pubmed/35192896 http://dx.doi.org/10.1016/j.jinf.2022.02.018 |
Ejemplares similares
-
Reduced neutralizing antibody response in naïve Covishield vaccinees against Omicron emphasizes booster vaccination
por: Yadav, Pragya D., et al.
Publicado: (2022) -
Elevated neutralization of Omicron with sera of COVID-19 recovered and breakthrough cases vaccinated with Covaxin than two dose naïve vaccinees
por: Yadav, Pragya D., et al.
Publicado: (2022) -
SARS-CoV-2 Delta Variant Pathogenesis and Host Response in Syrian Hamsters
por: Mohandas, Sreelekshmy, et al.
Publicado: (2021) -
Protective Immunity of the Primary SARS-CoV-2 Infection Reduces Disease Severity Post Re-Infection with Delta Variants in Syrian Hamsters
por: Mohandas, Sreelekshmy, et al.
Publicado: (2022) -
Pathogenicity of SARS-CoV-2 Omicron (R346K) variant in Syrian hamsters and its cross-neutralization with different variants of concern
por: Mohandas, Sreelekshmy, et al.
Publicado: (2022)